Litcius/Paper detail

US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer

Melanie Royce, Flora Mulkey, Christy Osgood, Erik Bloomquist, Laleh Amiri‐Kordestani

2023Journal of Clinical Oncology16 citationsDOI

Topics & Concepts

MedicineFood and drug administrationBreast cancerDrugAdjuvantOncologyCancerInternal medicinePharmacologyAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer Treatment and Pharmacology
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer | Litcius